In conclusion, the findings revealed that these three DEGs (APOE, SENP6, and ZNF148) may effectively differentiate between samples from ET patients and normal controls, hence providing a useful diagnostic tool. This evidence concerns the gene ZNF148 and essential thrombocythemia.